B, a stem-cell therapy for age-related frailty, at three longevity conferences in October, citing Phase 2b trial data. - The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results